The document discusses validation of pharmaceutical processes. It describes the key elements of validation including design qualification, installation qualification, operational qualification and performance qualification. It discusses different types of validation such as prospective validation, concurrent validation and retrospective validation. It also discusses revalidation which is needed when any changes are made that could impact quality. The validation process involves three phases - pre-validation, process validation and validation maintenance. A validation protocol and validation master plan are developed to document the validation activities and ensure a systematic approach.
Introduction to Pharmaceutical Validation, Scope & Merits of Validation, Validation and calibration of Master plan, Hrs ICH & WHO guidelines for calibration and validation of
equipment's, Validation of specific dosage form, Types of validation. Government regulation, Manufacturing Process Model, URS, DQ, IQ, OQ & P.Q. of facilities.
Documentation is an integral part of good manufacturing practices. It defines a system of information and control so that risks so inherent in misinterpretation and/or error in oral communication are minimized.
Introduction to Pharmaceutical Validation, Scope & Merits of Validation, Validation and calibration of Master plan, Hrs ICH & WHO guidelines for calibration and validation of
equipment's, Validation of specific dosage form, Types of validation. Government regulation, Manufacturing Process Model, URS, DQ, IQ, OQ & P.Q. of facilities.
Documentation is an integral part of good manufacturing practices. It defines a system of information and control so that risks so inherent in misinterpretation and/or error in oral communication are minimized.
Indian GMP Certification & WHO GMP CertificationVishal Shelke
Indian GMP Certification & WHO GMP Certification by Mr. Vishal Shelke
https://youtube.com/vishalshelke99
https://instagram.com/vishal_stagram
Sub :- Drug Regulatory Affairs
M.Pharm Sem II
Savitribai Phule Pune University
A brief presentation on the current good manufacturing practices employed in the manufacture of pharmaceuticals in the US.
Comprises of all aspects of good manufacturing practices
Process Validation is Key important factor for the Pharmaceutical Industry to maintain Consistent Quality in product which claimed by the manufacturer.
Documentation relating to product development,sop's,cleaning methods,quality ...swrk
COMPLAINT HANDLING IN PHARMACEUTICAL COMPANIES,PRODUCT RECALL,RETENTION RECORDS, DISTRIBUTION RECORDS.prepared by s.susena,m.pharmacy pharmaceutical analysis&QA,ssj college of pharmacy
Pharmaceutical Validation, its scope and types. Validation Team. validation Master plan. Validation protocols. Elements of Validation. Approaches of Validation. Dosage form Validation along with example of Validation of Tablet Dosage form.
IPQC cover the entire chain of operations from the receipt of raw material in the warehouse to the release of finished products from the warehouse for distribution and or sale. IPQC is a process where quality of a product is ensured that it meets the standard according to regulatory authority guidline.
Almost all the regulatory bodies are expected to have Risk Based Quality System. Quality Risk and its assessment has tremendous output and benefits towards the Patient Safety.
Indian GMP Certification & WHO GMP CertificationVishal Shelke
Indian GMP Certification & WHO GMP Certification by Mr. Vishal Shelke
https://youtube.com/vishalshelke99
https://instagram.com/vishal_stagram
Sub :- Drug Regulatory Affairs
M.Pharm Sem II
Savitribai Phule Pune University
A brief presentation on the current good manufacturing practices employed in the manufacture of pharmaceuticals in the US.
Comprises of all aspects of good manufacturing practices
Process Validation is Key important factor for the Pharmaceutical Industry to maintain Consistent Quality in product which claimed by the manufacturer.
Documentation relating to product development,sop's,cleaning methods,quality ...swrk
COMPLAINT HANDLING IN PHARMACEUTICAL COMPANIES,PRODUCT RECALL,RETENTION RECORDS, DISTRIBUTION RECORDS.prepared by s.susena,m.pharmacy pharmaceutical analysis&QA,ssj college of pharmacy
Pharmaceutical Validation, its scope and types. Validation Team. validation Master plan. Validation protocols. Elements of Validation. Approaches of Validation. Dosage form Validation along with example of Validation of Tablet Dosage form.
IPQC cover the entire chain of operations from the receipt of raw material in the warehouse to the release of finished products from the warehouse for distribution and or sale. IPQC is a process where quality of a product is ensured that it meets the standard according to regulatory authority guidline.
Almost all the regulatory bodies are expected to have Risk Based Quality System. Quality Risk and its assessment has tremendous output and benefits towards the Patient Safety.
Process validation incorporates a lifecycle approach linking product and process development, validation of the commercial manufacturing process and maintenance of the process in a state of control during routine commercial production.
The Validation Master Plan is a a valuable opportunity to provide an overview of your company’s validation process, including organization structure, content, and planning.
In the last year or so the FDA and the EMA have issued new guidance/ draft guidance on "Process Validation".These align process validation activities with a product lifecycle concept and the International Conference on Harmonisation (ICH) guidances for industry, Q8(R2) Pharmaceutical Development, Q9 Quality Risk Management, and Q10 Pharmaceutical Quality System. The earlier guidelines were developed before the elaboration of the new ICH guidelines.With these new guidelines, additional opportunities are available to verify the control of the process by alternative means to the manufacture of traditional process validation batches. The main objective of process validation remains that a process design yields a product meeting its pre-defined quality criteria. ICH Q8, Q9 and Q10 provide a structured way to define product critical quality attributes, design space, the manufacturing process and the control strategy. ICH Q8 refers to an ‘enhanced’ approach to pharmaceutical development which includes an alternative to the traditional process validation.
Continuous process verification [see definition in ICH Q8(R2) glossary] can be utilised in process validation protocols for the initial commercial production and for manufacturing process changes for the continual improvement throughout the remainder of the product lifecycle.
There is now a new paradigm in process validation. This presentation has been prepared from material available from FDA , EMA and ICH for beginners to have an overview of the new paradigm.
This presentation was made to solely for students to make them aware/ understand basics of “Validation”. These slides are part of lectures delivered in M. Pharmacy Curriculum & taken up from various books and websites
PHARMACEUTICAL QUALITY ASSURANCE SIXTH SEMSTER B PHARM
Introduction, definition and general principles of calibration, qualification
and validation, importance and scope of validation, types of validation, validation master plan. Calibration of pH meter, Qualification of UV-Visible spectrophotometer, General principles of Analytical
method Validation.
Complete discussion about the Pharmaceutical validation, its types, difference between calibration and validation, validation master & calibration master plan
PHARMACEUTICAL CALIBRATION & VALIDATION.
What is Validation?
What is calibration?
What are the types of Validation ?
Validation and calibration Basic Difference
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
2. DESCRIPTION
• As a process of establishing documented
evidence that establishes a high degree of
certainty that a particular process will
consistently a product that provides the
previously established specifications and
quality attributes are available.
3. Validation should thus be considered in the
following situations:
• Totally new process;
• New equipment;
• Process and equipment which have been
altered to suit changing priorities;
• Process where the end-product test is poor
and an unreliable indicator of product quality.
5. Design Qualification (DQ)
It is documented review of the design, at an appropriate stage of
stages in the project, for conformance to operational and regulatory
expectations.
DQ Check Items:
• GMPs and regulatory requirements
• Performance criteria
• Facility air flow, movement flow & pressure regimes
• Reliability & efficiency
• Commissioning requirements
• Construct ability & installation of equipment
• Maintenance & access to critical equipment & instrumentation
• Safety & environment impact
6. Installation Qualification (IQ)
It is documented verification that all aspects of a facility, utility or
equipment that can affect product quality adhere to approved
specifications and are correctly installed.
Important IQ considerations are:
• Installation conditions (wiring,utilities, and functionality)
• Calibration, preventative maintenance, cleaning schedules
• Safety features
• Supplier documentation, prints, drawings and manuals
• Software documentation
• Spare parts list
• Environmental conditions (such as clean room requirements,
temperature and humidity)
• Equipment design features (i.e. materials of construction
cleanability)
7. Operational Qualification (OQ)
It is documented verification that all aspects of a facility, utility or equipment
that can affect product quality operate to Intend throughout all anticipated
ranges.
OQ considerations include:
• Process control limits (time, temperature, pressure, line speed and setup
conditions)
• Software parameters
• Raw material specifications
• Process operating procedures
• Material handling requirements
• Process change control
• Training
• Short term stability and capability of the process, (latitude studies or
control charts)
• Potential failure modes, action levels and worst-case conditions (Failure
Mode and effects
• Fault tree analysis
8. Performance Qualification (PQ)
It is documented verification that all aspects of a
facility, utility or equipment perform as intended in
meeting predetermined acceptance criteria.
PQ considerations include:
• Actual product and process parameters and
procedures established in OQ
• Acceptability of the product
• Assurance of process capability as established in
OQ
• Process repeatability, long term process stability
10. Prospective validation
• Prospective validation is carried out during the
development stage by means of a risk analysis
of the production process, which is broken
down into individual steps: these are then
evaluated on the basis of past experience to
determine whether they might lead to critical
situations.
11. • Where possible critical situations are identified, the
risk is evaluated, the potential causes are investigated
and assessed for probability and extent, the trial plans
are drawn up, and the priorities set.
• The trials are then performed and evaluated, and an
overall assessment is made.
• If, at the end, the results are acceptable, the process is
satisfactory.
• Unsatisfactory processes must be modified and
improved until a validation exercise proves them to be
satisfactory.
• This form of validation is essential in order to limit the
risk of errors occurring on the production scale, e.g. in
the preparation of injectable products.
12. Concurrent validation
• Concurrent validation is carried out during normal
production. This method is effective only if the
development stage has resulted in a proper understanding
of the fundamentals of the process.
• The first three production-scale batches must be monitored
as comprehensively as possible.
• 1The nature and specifications of subsequent in-process
and final tests are based on the evaluation of the results of
such monitoring.
• 1 This careful monitoring of the first three production
batches is sometimes regarded as prospective validation.
•
Concurrent validation together with a trend analysis
including stability should be carried out to an appropriate
extent throughout the life of the product.
13. Retrospective validation
• Retrospective validation involves the examination of past
experience of production on the assumption that
composition, procedures, and equipment remain
unchanged; such experience and the results of in-process
and final control tests are then evaluated.
• Recorded difficulties and failures in production are
analysed to determine the limits of process parameters.
• A trend analysis may be conducted to determine the extent
to which the process parameters are within the permissible
range.
• Retrospective validation is obviously not a quality
assurance measure in itself, and should never be applied to
new processes or products. It may be considered in special
circumstances only, e.g. when validation requirements are
first introduced in a company.
14. • Retrospective validation may then be useful in
establishing the priorities for the validation
programme.
• If the results of a retrospective validation are positive,
this indicates that the process is not in need of
immediate attention and may be validated in
accordance with the normal schedule.
• For tablets which have been compressed under
individual pressure-sensitive cells, and with qualified
equipment, retrospective validation is the most
comprehensive test of the overall manufacturing
process of this dosage form.
• On the other hand, it should not be applied in the
manufacture of sterile products.
15. Revalidation
• Revalidation is needed to ensure that changes in the
process and/or in the process environment, whether
intentional or unintentional, do not adversely affect
process characteristics and product quality.
• Revalidation may be divided into two broad categories:
1. Revalidation after any change having a bearing on
product quality.
2. Periodic revalidation carried out at scheduled
intervals.
16. 1. Revalidation after any change
having a bearing on product quality.
• Revalidation must be performed on introduction of any
changes affecting a manufacturing and/or standard
procedure having a bearing on the established product
performance characteristics.
• Such changes may include those in starting material,
packaging material, manufacturing processes,
equipment, in-process controls, manufacturing areas,
or support systems (water, steam, etc.).
• Every such change requested should be reviewed by a
qualified validation group, which will decide whether it
is significant enough to justify revalidation and, if so, its
extent.
17. 2. Periodic revalidation carried out at
scheduled intervals.
• It is well known that process changes may occur gradually
even if experienced operators work correctly according to
established methods.
• Similarly, equipment wear may also cause gradual changes.
• Consequently, revalidation at scheduled times is advisable
even if no changes have been deliberately made.
• The decision to introduce periodic revalidation should be
based essentially on a review of historical data, i.e. data
generated during in-process and finished product testing
after the latest validation, aimed at verifying that the
process is under control.
• During the review of such historical data, any trend in the
data collected should be evaluated
19. Process validation is defined as the collection
and evaluation of data, from the process
design stage throughout production, which
establishes scientific evidence that a process is
capable of consistently delivering quality
products.
20. • Stage 1 - Process Design: The commercial process
is defined during this stage based on 100
knowledge gained through development and
scale-up activities.
• Stage 2 - Process Qualification: During this stage,
the process design is confirmed as 103 being
capable of reproducible commercial
manufacturing.
• Stage 3 - Continued Process Verification:
Ongoing assurance is gained during routine
production that the process remains in a state of
control.
22. Phase 1
• Pre-Validation Phase or the Qualification Phase,
which covers all activities relating to product
research and development, formulation, pilot
batch studies, scale-up studies, transfer of
technology to commercial scale batches,
establishing stability conditions, storage and
handling of in-process and finished dosage forms,
equipment qualification, installation qualification,
master production documents, operational
qualification, process capability.
23. Phase 2
• Process Validation Phase (Process
Qualification phase) designed to verify that all
established limits of the critical process
parameters are valid and that satisfactory
products can be produced even under the
"worst case" conditions.
24. Phase 3
• Validation Maintenance Phase requiring
frequent review of all process related documents,
including validation audit reports to assure that
there have been no changes, deviations, failures,
modifications to the production process, and that
all SOPs have been followed, including Change
Control procedures.
• At this stage the validation team also assures that
there have been no changes/ deviations that
should have resulted in requalification and
revalidation.
25. • The validation protocol provides a synopsis of
what is hoped to be accomplished.
• The protocol should list the selected process
and control parameters, state the number of
batches to be included in the study, and
specify how the data, once assembled, will be
treated for relevance.
• The date of approval by the validation team
should also be noted.
26. The validation protocol should be numbered, signed and dated,
and should contain as a minimum the following information:
1. Title
2. Objective & Scope
3. Responsibility
4. Protocol Approval
5. Validation Team
6. Product Composition
7. Process Flow Chart
8. Manufacturing Process
9. Review of Equipments /
Utilities
10.Review of Raw Materials and
Packing Materials
11. Review of Analytical and
Batch Manufacturing Records
12. Review of Batch Quantities for
Validation (Raw Materials)
13. Review of Batch Quantities for
Validation (Packing Materials)
14. HSE Requirements
15. Review of Process Parameters
16. Validation Procedure
17. Sampling Location
18. Documentation
19. Acceptance Criteria
20. Summary
21. Conclusion
27. • Validation Master Plan is a document that
summarizes the company's overall philosophy,
intentions and approaches to be used for
establishing performance adequacy. The
validation master plan should be agreed upon by
management.
• The validation master plan should provide an
overview of the entire validation operation, its
organizational structure, its content and planning.
The main elements include the list/inventory of
the items to be validated and planning schedule.
28. The format and content should include
• Introduction: validation policy, scope, location and schedule
• Organizational structure: personnel responsibilities
• Plant/ process /product description: rational for inclusions
or exclusions and extent of validation
• Specific process considerations that are critical and those
requiring extra attention
• List of products/ processes/ systems to be validated,
summarized in a matrix format, validation approach
• Re-validation activities, actual status and future planning
• Key acceptance criteria
• Documentation format
• Reference to the required sop's
• Time plans of each validation project and sub-project.